Artelo Biosciences Inc. Warrant (ARTLW) Peer Comparison

$0.01

$0.00 (9.80%)

As on 17-Jun-2024 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Edit

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Market cap ($ Mln)	0	5
Revenue ($ Mln)	--	4
Net Profit ($ Mln)	--	30.31
Net Margin (%)	--	842.30
RoE (%)	--	31.62
Price to Earnings	--	0.17
Price-To-Book	--	0.60

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Operating Revenue	0.00	3.60
Cost of Revenue	--	2.68
Gross Profit	--	-0.62
Operating Expenses	9.93	54.06
Operating Profit (EBIT)	-9.93	27.83
Other Income	--	0.00
Profit before Tax	-9.29	30.68
Provision for Tax	--	-2.57
Profit after Tax (Net Income)	-9.29	30.31
Minority Interest	--	0.00
Consolidated Profit	--	67.48

Liabilities ($ Mln)

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Shareholder's Funds	9.54	88.84
Minority Interest	--	0.00
Non-Current Liabilities	0.10	0.00
Current Liabilities	0.72	3.51
Total Liabilities	13.04	101.09

Assets ($ Mln)

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Non-Current Assets	2.17	0.51
Current Assets	8.19	91.84
Total Assets	--	101.09
Total Debt*	0.00	0.22
Net Current Assets	7.47	88.33

Cashflow ($ Mln)

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Cash From Operating Activities	-8.21	-63.19
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	0.57	-16.03
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
ROCE (%)	-59.51	12.90
ROE (%)	-59.63	31.62
ROA (%)	-55.51	31.81
EBIT Margin (%)	--	-1,439.53
Net Margin (%)	--	842.30
Cash Profit Margin (%)	--	0.00

Growth Ratios

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Revenue Growth (%)	--	--
EBIT Growth (%)	--	49.17
Net Profit Growth (%)	5.92	170.93
EPS Growth (%)	--	--
Book Value Growth (%)	--	--

Valuation Ratios

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Price / Earnings	--	--
Price / Book Value	--	--
Dividend Yield (%)	--	--
EV/EBITDA	--	1.37
Market Cap ($ Cr)	--	--

Solvency Ratios

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.00	0.00
Current Ratio	11.36	26.17
Quick Ratio	11.36	26.17
Interest Coverage	--	15.13

Operating Efficiency Ratios

	Artelo Biosciences Inc. Warrant (ARTLW)	AVROBIO (AVRO)
Debtors to sales (%)	--	0.00
Asset Turnover	0.00	0.04
Receivable days	--	--
Inventory Days	--	-159.24
Payable days	--	121.65
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly